Launch of EyePad Bioware delayed to 2051
Tokyo, March 17, 2050: Eyeware enthusiasts were weeping behind their shades today when Applesoft announced that European and Chinese regulators had asked for further clinical studies before they would consider approving the new bioware upgrade to the ubiquitious EyePad.
Applesoft had planned to launch EyePad Bioware in June this year, following what it claimed were successful clinical trials of the new EyePad’s surgically implantable sensory enhancement unit.
Published clinical study data indicates subjects who had the unit implanted, reported being able to hear, smell and taste in-game special effects.
Yahoogle Game Industry Analyst, Charles Chang, said he had seen confidential company data which was part of the EU and China submissions, showing that gamers using the implant also experienced dramatic weight gain and other side effects.
"It may just be an issue of the advertising and product placement in the games," he said. "Sonysoft chose to test the units using the RazorWire III game, which includes significant product placement from fast food companies. My sources tell me that in one study they enabled the sensory effects for the food in the game, causing subjects to dramatically increase their snacking behaviour. This is what is worrying regulators."
The vocal Taipei based Eyeware Consumer Protection Organization issued a news release praising the decision to request further clinical studies before approving the implant.
"Multiple independent studies show that long term Eyeware use can lead to social isolation, depression, aggressive behaviour and crime – all behaviours reminiscent of drug addiction," said Garda McVeigh, spokesperson for the ECPO.
"We remain deeply concerned about the impact of adding sensory enhancement to an already dangerous machine," she said. "Our information is that it is not just weight which increased in trial subjects, but also sexual self abuse."
There are currently estimated to be 1.2bn Eyeware users globally. Applesoft has captured nearly 80% of the Eyeware market with its EyePad glasses, a gaming and content viewing platform with Omninet capability.
A perceived limitation of the system is that to hear audio, users must still place earbuds in their ears. The Applesoft implant was intended to address this by providing audio direct to the aural nerve, but Applesoft also chose to explore in clinical studies the opportunity to stimulate other sensory organs with the upgrade.
"One option for Applesoft is to drop the taste, smell and other enhancers and bring the unit to market now with just the audio feature," Yahoogle’s Chang said. "The question for Applesoft marketing though - are people willing to undergo a surgical procedure just to avoid having to wear earbuds?"
"The Applesoft pipeline includes a next-gen version of the EyePad for contact lenses – I believe they would be better off trying to accelerate that product, than to keep going with Bioware now," he said.
Tokyo, March 17, 2050: Eyeware enthusiasts were weeping behind their shades today when Applesoft announced that European and Chinese regulators had asked for further clinical studies before they would consider approving the new bioware upgrade to the ubiquitious EyePad.
Applesoft had planned to launch EyePad Bioware in June this year, following what it claimed were successful clinical trials of the new EyePad’s surgically implantable sensory enhancement unit.
Published clinical study data indicates subjects who had the unit implanted, reported being able to hear, smell and taste in-game special effects.
Yahoogle Game Industry Analyst, Charles Chang, said he had seen confidential company data which was part of the EU and China submissions, showing that gamers using the implant also experienced dramatic weight gain and other side effects.
"It may just be an issue of the advertising and product placement in the games," he said. "Sonysoft chose to test the units using the RazorWire III game, which includes significant product placement from fast food companies. My sources tell me that in one study they enabled the sensory effects for the food in the game, causing subjects to dramatically increase their snacking behaviour. This is what is worrying regulators."
The vocal Taipei based Eyeware Consumer Protection Organization issued a news release praising the decision to request further clinical studies before approving the implant.
"Multiple independent studies show that long term Eyeware use can lead to social isolation, depression, aggressive behaviour and crime – all behaviours reminiscent of drug addiction," said Garda McVeigh, spokesperson for the ECPO.
"We remain deeply concerned about the impact of adding sensory enhancement to an already dangerous machine," she said. "Our information is that it is not just weight which increased in trial subjects, but also sexual self abuse."
There are currently estimated to be 1.2bn Eyeware users globally. Applesoft has captured nearly 80% of the Eyeware market with its EyePad glasses, a gaming and content viewing platform with Omninet capability.
A perceived limitation of the system is that to hear audio, users must still place earbuds in their ears. The Applesoft implant was intended to address this by providing audio direct to the aural nerve, but Applesoft also chose to explore in clinical studies the opportunity to stimulate other sensory organs with the upgrade.
"One option for Applesoft is to drop the taste, smell and other enhancers and bring the unit to market now with just the audio feature," Yahoogle’s Chang said. "The question for Applesoft marketing though - are people willing to undergo a surgical procedure just to avoid having to wear earbuds?"
"The Applesoft pipeline includes a next-gen version of the EyePad for contact lenses – I believe they would be better off trying to accelerate that product, than to keep going with Bioware now," he said.
No comments:
Post a Comment